-
Section Summary Section (2.16.840.1.113883.10.20.20.1.1)
-
Section Indications Section (2.16.840.1.113883.10.20.20.1.11)
-
Entry Indication Observation (2.16.840.1.113883.10.20.20.3.3)
-
Entry Genetic Disease Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.1)
-
Entry Medication Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.2)
-
Section Summary Of Tests Performed Section (2.16.840.1.113883.10.20.20.1.1.6)
-
Entry Test Performed Observation (2.16.840.1.113883.10.20.20.3.4)
-
Section Overall Interpretation Section (2.16.840.1.113883.10.20.20.1.1.1)
-
Entry Clinical Genomic Statement Overall Interpretation (2.16.840.1.113883.10.20.20.2.4)
-
Entry Genomic Observations Organizer (2.16.840.1.113883.10.20.20.5.1)
-
Entry Genomic Observation Reference (2.16.840.1.113883.10.20.20.6)
-
Section Recommendations Section (2.16.840.1.113883.10.20.20.1.1.5)
-
Section Specimen Section (2.16.840.1.113883.10.20.20.1.7)
-
Entry Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
|